$VOO stock has risen 0.6% today, according to our price data from Polygon. It has been bolstered by JNJ stock rising 2.5%.
Here are some of the largest contributors to VOO's gains:
- $NVDA (7.3% of VOO holdings) has risen 2.4%
- $AMZN (3.5%) has risen 1.8%
- $AAPL (6.6%) has risen 0.7%
- $AMD (0.6%) has risen 6.1%
- $TSLA (1.9%) has risen 1.5%
- $INTC (0.3%) has risen 7.3%
- $META (2.4%) has risen 1.1%
- $JNJ (1.0%) has risen 2.5%
- $LLY (1.4%) has risen 1.5%
- $AVGO (2.6%) has risen 0.7%
You can track more data on $VOO on Quiver Quantitative's $VOO data dashboard.
$JNJ Insider Trading Activity
$JNJ insiders have traded $JNJ stock on the open market 19 times in the past 6 months. Of those trades, 1 have been purchases and 18 have been sales.
Here’s a breakdown of recent trading of $JNJ stock by insiders over the last 6 months:
- JOAQUIN DUATO (CEO and Chairman of the Board) has made 0 purchases and 2 sales selling 100,000 shares for an estimated $22,122,893.
- JOSEPH J WOLK (Exec VP, CFO) has made 0 purchases and 4 sales selling 89,654 shares for an estimated $21,767,826.
- JOHN C REED (EVP, Innovative Medicine, R&D) has made 0 purchases and 4 sales selling 75,652 shares for an estimated $17,291,026.
- JAMES D. SWANSON (EVP, CIO) has made 0 purchases and 3 sales selling 62,080 shares for an estimated $15,109,758.
- TIMOTHY SCHMID (EVP, WW Chair, MedTech) has made 0 purchases and 3 sales selling 23,945 shares for an estimated $5,852,268.
- VANESSA BROADHURST (EVP, Global Corp Affairs) sold 6,197 shares for an estimated $1,508,287
- ROBERT J DECKER (VP Corporate Controller) sold 4,075 shares for an estimated $1,010,070
- JOHN G MORIKIS purchased 1,250 shares for an estimated $257,687
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$JNJ Analyst Ratings
Wall Street analysts have issued reports on $JNJ in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Overweight" rating on 01/28/2026
- TD Cowen issued a "Buy" rating on 01/22/2026
- Goldman Sachs issued a "Buy" rating on 12/19/2025
- Guggenheim issued a "Buy" rating on 12/05/2025
- UBS issued a "Buy" rating on 10/14/2025
- Citigroup issued a "Buy" rating on 10/07/2025
- Wells Fargo issued a "Overweight" rating on 10/03/2025
To track analyst ratings and price targets for $JNJ, check out Quiver Quantitative's $JNJ forecast page.
$JNJ Price Targets
Multiple analysts have issued price targets for $JNJ recently. We have seen 17 analysts offer price targets for $JNJ in the last 6 months, with a median target of $240.0.
Here are some recent targets:
- Matt Miksic from Barclays set a target price of $234.0 on 03/19/2026
- Morten Herholdt from HSBC set a target price of $280.0 on 03/17/2026
- Joanne Wuensch from Citigroup set a target price of $274.0 on 03/11/2026
- Chris Schott from JP Morgan set a target price of $250.0 on 03/05/2026
- Shagun Singh from RBC Capital set a target price of $255.0 on 02/03/2026
- Terence Flynn from Morgan Stanley set a target price of $262.0 on 01/28/2026
- Ilya Zubkov from Freedom Capital Markets set a target price of $220.0 on 01/27/2026
You can track data on $JNJ on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
